Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Asian Pacific Journal of Tropical Biomedicine ; (12): 531-538, 2019.
Article in Chinese | WPRIM | ID: wpr-950332

ABSTRACT

Objective: To identify the potential target and mechanisms of hesperidin in MCF-7 estrogen receptor-positive breast cancer cells using bioinformatics approaches. Methods: Gene expression profiles were accessed from public database GSE85871. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was carried out with Database for Annotation, Visualization and Integrated Discovery. The protein-protein interaction network was analyzed by STRING-DB and visualized by Cytoscape. Transcription factor regulatory networks were constructed from TRED, TRRUST, RegNetwork and visualized by Cytoscape. Drug association analysis was conducted by WebGestalt. Results: GO and KEGG pathway enrichment analysis revealed biological processes, cellular components and molecular functions that were related to cancer and estrogen signaling pathways. KEGG pathway enrichment analysis of the genes in transcription factor-differential expression genes regulatory network showed regulation of cancer, estrogen signaling pathways, epidermal growth factor receptor tyrosine kinase inhibitor resistance, and endocrine resistance. Moreover, drug association analysis revealed that hesperidin affected the expression of the same gene as raloxifene. Conclusions: Hesperidin targets estrogen receptor signaling in estrogen receptor-positive breast cancer cells. Results of this study could trace the molecular mechanism of hesperidin in estrogen receptor-positive breast cancer cells and integrative bioinformatics analysis could accelerate drug discovery and development.

2.
IJPR-Iranian Journal of Pharmaceutical Research. 2014; 13 (3): 919-926
in English | IMEMR | ID: emr-196706

ABSTRACT

New approach of breast cancer therapy is developed toward combination therapy with agent that have a specific molecular target. Our previous study showed that Citrus aurantifolia lime peels ethanolic extract [CPE] increased the sensitivity of MCF-7 cells againts doxorubicin. This study aims to observe the mechanism of combination CPE and doxorubicin in cell cycle modulation and apoptosis on MCF-7 cells. The assays were performed in the study were cell cycle assay, apoptosis induction, and immunocytochemistry of MCF-7 cells. The effect on the modulation of cell cycle and apoptosis were observed by flowcytometry assay in both single dose of CPE and its combination with Doxorubicin. Cell cycle distribution were observed with flowcytometer FACS-Calibur and its data was analyzed by Cell Quest program. Apoptotic induction in MCF-7 cells was examined using acrydine orange-ethidium bromide [AO-EtBr] double staining. Immunocytochemistry assay was done to observe the expression of apoptotic regulation protein p53 and Bcl-2. The result showed that CPE 6 microg/mL induced apoptosis and cell accumulation at G1 phase, while CPE 15 microg/mL induced apoptosis and cell accumulation at G2/M phase. The combination of doxorubicin 200 nM with CPE 6 microg/mL increased apoptosis induction than their single treatment, and cell accumulation at G2/M phase. Evidence of apoptosis and protein expression of p53 and Bcl-2 indicated that both single applications and combinations of CPE and doxorubicin is able to increase apoptotic bodies of MCF-7 cells by increasing the proteins expression. This results suggested that CPE could perform as co-chemotherapeutic agent with doxorubicin on breast cancer cells

3.
Asian Pacific Journal of Tropical Biomedicine ; (12): 297-302, 2013.
Article in English | WPRIM | ID: wpr-312412

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the effects of n-hexane insoluble fraction (HIF) of Ficus septica leaves in combination with doxorubicin on cytotoxicity, cell cycle and apoptosis induction of breast cancer T47D cell lines.</p><p><b>METHODS</b>The in vitro drugs-stimulated cytotoxic effects were determined using MTT assay. Analysis of cell cycle distribution was performed using flowcytometer and the data was analyzed using ModFit LT 3.0 program. Apoptosis assay was carried out by double staining method using ethydium bromide-acridin orange. The expression of cleaved-poly (ADP-ribose) polymerase (PARP) on T47D cell lines was identified using immunocytochemistry.</p><p><b>RESULTS</b>The combination exhibited higher inhibitory effect on cell growth than the single treatment of doxorubicin in T47D cells. In addition, combination of doxorubicin and HIF increased the incidence of cells undergoing apoptosis. HIF could improve doxorubicin cytotoxic effect by changing the accumulation of cell cycle phase from G2/M to G1 phase. The combination also exhibited upregulation of cleaved-PARP in T47D cells.</p><p><b>CONCLUSIONS</b>Based on this results, HIF is potential to be developed as co-chemotherapeutic agent for breast cancer by inducing apoptosis and cell cycle arrest. However, the molecular mechanism need to be explored further.</p>


Subject(s)
Female , Humans , Antineoplastic Agents , Chemistry , Pharmacology , Apoptosis , Breast Neoplasms , Cell Cycle , Cell Line, Tumor , Cell Survival , Doxorubicin , Pharmacology , Ficus , Chemistry , Flow Cytometry , Hexanes , Chemistry , Pharmacology , Immunohistochemistry , Solubility
4.
Asian Pacific Journal of Tropical Biomedicine ; (12): 371-375, 2013.
Article in English | WPRIM | ID: wpr-312399

ABSTRACT

<p><b>OBJECTIVE</b>To observe the combination effect of doxorubicin and Citrus hystrix (kaffir lime's) peel ethanolic extract (ChEE) on blood serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity and cardio-hepato-histopathology of female Sprague Dawley rats.</p><p><b>METHODS</b>Doxorubicin and ChEE (5 rats per group) were administered in five groups of 3 rats each for 11 d. Group I: doxorubicin (dox) 4.67 mg/kg body weight; Group II: dox+ChEE 500 mg/kg body weight; Group III: dox+ChEE 1 000 mg/kg body weight; Group IV: ChEE 1 000 mg/kg body weight; Group V: untreated (control).</p><p><b>RESULTS</b>ChEE repaired cardiohistopathology profile of doxorubicin induced cardiotoxicity and hepatotoxicity rats, but did not repair neither hepatohistopathology profile nor reduce serum activity of ALT and AST.</p><p><b>CONCLUSION</b>ChEE has potency to be developed as cardioprotector agent in chemotherapy.</p>


Subject(s)
Animals , Female , Rats , Alanine Transaminase , Blood , Metabolism , Aspartate Aminotransferases , Blood , Metabolism , Citrus , Chemistry , Doxorubicin , Pharmacology , Toxicity , Heart , Liver , Metabolism , Pathology , Myocardium , Metabolism , Pathology , Plant Extracts , Chemistry , Pharmacology , Protective Agents , Chemistry , Pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL